Submissions for variant NM_001271208.2(NEB):c.7839G>C (p.Lys2613Asn) (rs13013209)

Total submissions: 11

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics	RCV000081143	SCV000113051	benign	not specified	2013-08-23	criteria provided, single submitter	clinical testing
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine	RCV000081143	SCV000269437	benign	not specified	2014-11-26	criteria provided, single submitter	clinical testing	p.Lys2613Asn in exon 57 of NEB: This variant is not expected to have clinical si gnificance because it has been identified in 47% (3979/8400) of European America n chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u/EVS/; dbSNP rs13013209).
PreventionGenetics,PreventionGenetics	RCV000081143	SCV000307392	benign	not specified		criteria provided, single submitter	clinical testing
Illumina Clinical Services Laboratory,Illumina	RCV000361795	SCV000416962	benign	Nemaline myopathy 2	2018-01-12	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx	RCV000081143	SCV000519516	benign	not specified	2016-01-25	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp	RCV000589805	SCV000697838	benign	not provided	2017-04-24	criteria provided, single submitter	clinical testing	Variant summary: The NEB c.7839G>C (p.Lys2613Asn) variant involves the alteration of a conserved nucleotide and 2/3 in silico tools (SNPs&GO and Mutation Taster not captured here due to low reliability index and p-value, respectively) predict a damaging outcome. This variant was found in 50096/120722 control chromosomes (11150 homozygotes) from ExAC at a frequency of 0.4149699, which is approximately 117 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), thus this variant is a common benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign/likely benign. Therefore, the variant of interest has been classified as Benign.
Invitae	RCV000361795	SCV001722612	benign	Nemaline myopathy 2	2020-12-04	criteria provided, single submitter	clinical testing
Nilou-Genome Lab	RCV001542875	SCV001761268	benign	ARTHROGRYPOSIS MULTIPLEX CONGENITA 6	2021-07-10	criteria provided, single submitter	clinical testing
Nilou-Genome Lab	RCV000361795	SCV001761269	benign	Nemaline myopathy 2	2021-07-10	criteria provided, single submitter	clinical testing
Genetic Services Laboratory, University of Chicago	RCV000081143	SCV000152031	likely benign	not specified		no assertion criteria provided	clinical testing	Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.
Natera, Inc.	RCV000361795	SCV001463535	benign	Nemaline myopathy 2	2020-09-16	no assertion criteria provided	clinical testing